Virtu Financial LLC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 82 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$13
-100.0%
11,335
-79.2%
0.00%
-93.9%
Q1 2022$452,000
+283.1%
54,493
+139.4%
0.03%
+175.0%
Q4 2021$118,000
+19.2%
22,759
+87.1%
0.01%
-29.4%
Q3 2020$99,000
-28.8%
12,162
-15.9%
0.02%
+6.2%
Q2 2020$139,00014,4590.02%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Vivo Capital, LLC 1,787,091$20,462,0006.02%
INTERWEST VENTURE MANAGEMENT CO 1,599,592$18,315,0003.89%
NEXTHERA CAPITAL LP 263,600$3,018,0001.54%
SPHERA FUNDS MANAGEMENT LTD. 385,301$4,412,0000.86%
RA Capital Management 354,200$4,056,0000.50%
DAFNA Capital Management LLC 35,977$412,0000.35%
Boxer Capital, LLC 138,331$1,584,0000.35%
SABBY MANAGEMENT, LLC 238,907$2,735,0000.15%
Monashee Investment Management LLC 31,500$361,0000.14%
Lombard Odier Asset Management (USA) Corp 100,000$1,145,0000.11%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders